Pharmacology
| Action | Mechanism of Action | Reference |
|---|---|---|
| INHIBITOR | Sclerostin inhibitor | Other |
Indications
| Mesh Heading | Maximum Phase | Mesh ID | Reference |
|---|---|---|---|
| Bone Diseases, Metabolic | 1 | D001851 | ClinicalTrials |
Cross References
| Resources | Reference |
|---|---|
| ChEMBL | CHEMBL2109571 |
CONTENTS